Fengmei Pi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
32
Citations
1,387
Est. group size
—
Recurring co-author estimate
Active years
17
Publishing since 2010
Fengmei Pi's research focuses on RNA nanotechnology, particularly designing and building RNA-based nanoparticles (tiny structures assembled from RNA molecules) for targeted delivery of drugs, such as cancer therapeutics and asthma treatments. Work also extends into exosomes (small cell-derived vesicles used to carry molecules like microRNA) and, more recently, computational generation of therapeutic mRNA sequences using machine learning approaches.
Publication output has been irregular over the last decade, with gaps in some years, a peak of 5 papers in 2022, and a modest average of under 2 papers per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- mRNAutilus: Multi-Objective-Guided Discrete Generation of mRNA with Optimized Therapeutic Properties
arXiv (Cornell University) · 2026
- mRNAutilus: Multi-Objective-Guided Discrete Generation of mRNA with Optimized Therapeutic Properties
arXiv (Cornell University) · 2026
- <i>In Vitro</i> and <i>In Vivo</i> Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles
Molecular Pharmaceutics · 2024
- Effective delivery of miR-511-3p with mannose-decorated exosomes with RNA nanoparticles confers protection against asthma
Journal of Controlled Release · 2023
- Tuning the Size, Shape, and Structure of RNA Nanoparticles for Favorable Cancer Targeting and Immunostimulation 1
2022
- Conjugation of RNA Aptamer to RNA Nanoparticles for Targeted Drug Delivery
2022
- Purification of RNA, Modified Oligos, and RNA Nanoparticles
2022
- Method of Large-Scale Exosome Purification and Its Use for Pharmaceutical Applications
2022
- Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 2019
- Abstract 3147: A novel next generation sequencing strategy for detecting microsatellite instability in colorectal and gastric cancer
Cancer Research · 2019
- Abstract NT-112: APTAMER CONJUGATED NANOPARTICLES FOR TARGETED DRUG DELIVERY
Clinical Cancer Research · 2019
- Abstract 3147: A novel next generation sequencing strategy for detecting microsatellite instability in colorectal and gastric cancer
Clinical Research (Excluding Clinical Trials) · 2019
- RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications
Wiley Interdisciplinary Reviews - RNA · 2017
- Abstract NTOC-109: MULTI–FUNCTIONAL RNA NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTIC DRUGS FOR OVARIAN CANCER
Clinical Cancer Research · 2017
- Controllable Self‐Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting
Advanced Materials · 2016
- Clinical Cancer Research×2
- arXiv (Cornell University)×2
- Nature Nanotechnology×1
- Advanced Materials×1
- Journal of Controlled Release×1
- Sijin Guo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Congcong Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Dan Shu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yizhou Dong
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- L. James Lee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile